Background: Psychiatric comorbidity is associated with lower quality of life, more fatigue,
and reduced adherence to disease-modifying therapy in multiple sclerosis (MS). Objectives …

Background Mental comorbidity is common in multiple sclerosis (MS), but some studies
suggest that mental comorbidity may be underrecognized and undertreated. Objective Using …

Objective Prevalence rates of depression and anxiety in patients with Multiple Sclerosis
(MS) vary widely across studies. Aim of this systematic review and meta-analysis was to a) …

Background: Studies of depression and anxiety in multiple sclerosis (MS) patients have
reported higher rates in MS patients than the general population. Objective: To estimate the …

Background While mental comorbidity is considered common in multiple sclerosis (MS), its
impact is poorly defined; methods are needed to support studies of mental comorbidity. We …

Objective: We aimed to compare the incidence and prevalence of psychiatric comorbidity in
the multiple sclerosis (MS) population and in controls matched for age, sex, and geographic …

Objective Emerging evidence suggests that comorbidity may influence disability outcomes in
multiple sclerosis (MS); we investigated the association between psychiatric comorbidity and …

Multiple sclerosis (MS) is a chronic neurodegenerative and autoimmune disease. Motor,
sensory and cognitive deficits in MS are commonly accompanied by psychiatric disorders …

Objective: To determine the prevalence of major depression in multiple sclerosis (MS) in a
population-based sample controlling for nonspecific illness effects. Methods: This study …

Multiple sclerosis (MS) is the most common chronic disabling disease of the central nervous
system in young adults. Early onset and long duration of disease result in tremendous …